X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Nutrition and health bars expand market share by tying into wellness, athleticism

Yuvraj_pawp by Yuvraj_pawp
18th January 2016
in Research & Development

Nutrition and health bars are stealing market share from the category leading snack and cereal bars in part because they tie into the health and wellness trend dominating many consumers’ purchasing decisions in a way snack and cereal bars don’t, according to research analysis from Synergy Flavors.

Within the snack and nutrition bar category, snack and cereal bars still take the lion’s share of sales, accounting for 60% of sales worth $3.3 billion in 2013, according to Synergy. But, it notes, this is down 8 percentage points from 2011, with nutritional and health bars making up the difference in 2013.

“Nutritional/health bars grew 34% between 2011 and 2013, reaching $2.2 billion and 39.6% of share. This shift reflects the popularity of nutritional bars, driven by an expanding number of nutritional bar attributes, such as snacking, meal replacement, sweet/salty indulgence, workout fuel and so on, on top of expectations that these products will provide nutrition and good taste,” according to synergy


Some of this growth also is expanding the bar category overall. Sales growth of snack and nutrition bars climbed 2.9% to reach $5.5 billion in 2013 compared to the previous year, according to data from Mintel, which projects the category “will continue to grow at this moderate pace into 2018, when sales are expected to reach $6.2 billion.”

A main driver of nutrition bar sales has been the positioning of the bars as fuel for athleticism, Synergy notes. For example, it says, CLIF markets primarily to active people by sponsoring extreme athletes and chronicling how their diet impacts performance. Kashi also sponsors athletes, such as 2014 Olympic cross-country skier Kikkan Randall.

Claims that nutrition bars have no or reduced allergens or are gluten-free is another category sales driver, according to Mintel data. In 2013, 61% of bars launched claimed to have low, no or reduced allergens or be gluten-free – up 30.2% from launches in 2012. Other top claims seeing strong growth in product bar launches in 2014 include low, no or reduced sugar (42.1% of launches), high or added fiber (34.2% of launches) and no additives or preservatives (18.4% of launches).

Launches of high protein bars also are on the rise and expanding the overall category’s sales, according to data from Mintel’s Global New Products Database. Launches in this segment increased 126.9% from 26 in 2012 to 59 in 2013, and data suggest launches in 2014 will exceed this.

Push bar sales higher with consumer education

Synergy says manufacturers can further increase bar sales through increased consumer education and exposure.

For example, by better explaining the value of nutrition bars, manufacturers can overcome price, which is a major obstacle for bar sales. Mintel data found 42% of people who did not buy nutrition bars believed they were overpriced.

“This suggests that more expensive brands can do more to show how their products represent value in some other way, such as using natural or organic ingredients or being more convenient than other brands,” To expose more consumers to nutrition bar brands, manufacturers should offer more in-store sampling, Synergy suggests. It adds manufacturers of bars with flavors “inspired by sweet treats” could do a side-by-side sampling comparison of the nutrition bar and its snack or candy bar equivalent and use the event as “an opportunity to explain the nutritional advantage offered by the athletic bar compared to the competitive options.”

Finally, Synergy suggests bar makers explore line extensions such as portion-controlled packages and formulas with fewer calories than needed by serious athletes in order to court non-athletes interested in bars for convenience.

Previous Post

Merck’s BRIDION® (sugammadex) Receives FDA Approval for the Reversal of Neuromuscular Blockade Induced by Rocuronium and Vecuronium in Adults Undergoing Surgery

Next Post

How pharma can stay competitive in the digital world

Related Posts

News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
Report Indicates UK £62bn Behind In Global R&D Investment
News

Report Indicates UK £62bn Behind In Global R&D Investment

3rd November 2022
News

Once More, M&As In Biotechechnology Industry Are Thriving

2nd November 2022
DNA
News

Ancient Viral DNA Guards Against Infections In Human Genome

31st October 2022
News

Omicron Subvariants Withstand Essential Antibody Treatments

31st October 2022
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Research And Development In UK Falls Behind Other Nations

28th October 2022
Next Post

How pharma can stay competitive in the digital world

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In